DeviceTalks Boston Archives - Page 4 of 5

Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’

David Neustaedter is Medtronic’s VP of venture investments [Photo courtesy of Medtronic]

A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, VP of venture capital at Medtronic (NYSE: MDT).

He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company. (Read more in his DeviceTalks speaker bio.)

Medtronic has more than $500 million in venture investments, managed by Neustaedter’s group and others in the company. Every investment handled by his group requires two things.

“The first is we expect top-tier institutional venture returns on investments, and we’ve pulled that off for the last 14 years. So we’re sticking with that,” he said. “And then the second is really strategic fit with Medtronic. The usual form for that is, ‘Is this a company th…

Here’s where Harvard’s engineering dean sees medtech research going

Harvard University constructed a 500,000-square-foot Science and Engineering Complex (SEC) for SEAS in Boston’s Allston neighborhood in 2020. [Image courtesy of Harvard SEAS]

Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited.

Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking out a strong position when it comes to medtech innovation.

Doyle noted that the school he runs has 5% of the faculty — and produces 40% of the startups out of Harvard.

Get the full story at our sister site, MassDevice.

Here’s where Harvard’s engineering dean sees medtech research going

Harvard University constructed a 500,000-square-foot Science and Engineering Complex (SEC) for SEAS in Boston’s Allston neighborhood in 2020. [Image courtesy of Harvard SEAS]Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited.

Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking a strong position when it comes to medtech innovation.

Doyle noted that the school he runs has 5% of the faculty — and produces 40% of the startups out of Harvard.

The university constructed a 500,000-square-foot Science and Engineering Complex (SEC) for SEAS in Boston’s Allston neighborhood in 2020. Other exciting developments include a $500 million gift from Priscilla Chan and Mark Zuckerberg …

Meet a wide range of medical device suppliers at DeviceTalks Boston

[Image from Unsplash]DeviceTalks Boston is shaping up to be a great chance not only to hear from top medtech leaders and network with more than 700 industry insiders — but also to meet the dozens of medical device industry suppliers exhibiting on the show floor.

Exhibitors at the Boston Convention and Exhibitor Center — May 10–11, 2022 — include contract manufacturers such as Freudenberg Medical, Tegra Medical and Viant; law firms such as Greenberg Traurig; software and design outfits such as ICS and Propel; and much more.

Check out the full expo floor map for DeviceTalks Boston and our sister Robotics Summit show.

And there’s still time to register!

Meet a wide range of medical device suppliers at DeviceTalks Boston

[Boston image from Unsplash]

DeviceTalks Boston is shaping up to be a great chance not only to hear from top medtech leaders and network with more than 700 industry insiders — but also to meet the dozens of medical device industry suppliers exhibiting on the show floor.

Exhibitors at the Boston Convention and Exhibitor Center — May 10–11, 2022 — include contract manufacturers such as Freudenberg Medical, Tegra Medical and Viant; law firms such as Greenberg Traurig; software and design outfits such as ICS and Propel; and much more.

Check out the full expo floor map for DeviceTalks Boston and our sister Robotics Summit show.

And there’s still time to register!

DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11

BOSTON – Twenty-six mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event.

The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the medical device community, and MedTech Innovator, the world’s largest medical technology accelerator.

“We’re proud to host MedTech Innovator at DeviceTalks Boston,” says Tom Salemi, editorial director of DeviceTalks. “Paul Grand and his team do more than help medical device companies tell their stories. They provide a best-in-class global network of corporate partners, advisors and investors that build strong new device and healthtech companies.”

DeviceTalks Boston attendees will be invited to watch the presentations as part of the event’s “Innovation & Investment” track on …

DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11

BOSTON – Twenty-six mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event.

The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the medical device community, and MedTech Innovator, the world’s largest medical technology accelerator.

“We’re proud to host MedTech Innovator at DeviceTalks Boston,” says Tom Salemi, editorial director of DeviceTalks. “Paul Grand and his team do more than help medical device companies tell their stories. They provide a best-in-class global network of corporate partners, advisors and investors that build strong new device and healthtech companies.”

DeviceTalks Boston attendees will be invited to watch the presentations as part of the event’s “Innovation & Investment” track on …

How Stryker is advancing digital healthcare

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]

Count Stryker among the big medical device companies that have pioneered the transition toward digital, becoming medtech companies offering an array of software and services around their products.

The company’s popular Mako robotic surgery systems are more than just the robot when it comes to knee and hip surgeries. There’s the preoperative data modeling and planning. Plus, software and displays assist the surgeon with navigation during the surgery.

It is but one of the examples of the journey the world’s largest orthopedic device company has been on when it comes to improving outcomes through digital technology. Come to DeviceTalks Boston — May 10–11, 2022 — and discover more about how Stryker is accelerating its delivery of these technologies through organic inn…

How Stryker is advancing digital healthcare

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]Count Stryker among the big medical device companies that have pioneered the transition toward digital, becoming medtech companies offering an array of software and services around their products.

The company’s popular Mako robotic surgery systems are more than just the robot when it comes to knee and hip surgeries. There’s the preoperative data modeling and planning. Plus, software and displays assist the surgeon with navigation during the surgery.

It is but one of the examples of the journey the world’s largest orthopedic device company has been on when it comes to improving outcomes through digital technology. Come to DeviceTalks Boston — May 10–11, 2022 — and discover more about how Stryker is accelerating its delivery of these technologies through organic innovation and M&A.

A panel of leaders from the compa…

How Johnson & Johnson’s DePuy Synthes is shifting toward digital

Johnson & Johnson is increasingly digitizing in the medical device space, with the company even recently rebranding the business to Johnson & Johnson MedTech to reflect the shift.

Many medtech companies have embraced the trend. It’s all about providing software, knowledge and insights to boost healthcare outcomes and hopefully help the system operate more efficiently — versus simply providing devices.

Not only is J&J transforming in-house, but it’s engaging in M&A to boost its offerings. MedTech’s EVP Ashley McEvoy said during the company’s Q1 earnings call: “We’re going to continue to do tuck-ins and to really digitize the patient experience.”

Come to DeviceTalks Boston, May 10-11, 2022, and hear a panel of top officials from J&J’s DePuy Synthes discuss how the company is evolving.

They’ll discuss how DePuy Synthes is changing its product development process, setting up a s…

How Johnson & Johnson’s DePuy Synthes is shifting toward digital

Johnson & Johnson is increasingly digitizing in the medical device space, with the company even recently rebranding the business to Johnson & Johnson MedTech to reflect the shift.

Many medtech companies have embraced the trend. It’s all about providing software, knowledge and insights to boost healthcare outcomes and hopefully help the system operate more efficiently — versus simply providing devices.

Not only is J&J transforming in-house, but it’s engaging in M&A to boost its offerings. MedTech’s EVP Ashley McEvoy said during the company’s Q1 earnings call: “We’re going to continue to do tuck-ins and to really digitize the patient experience.”

Come to DeviceTalks Boston, May 10-11, 2022, and hear a panel of top officials from J&J’s DePuy Synthes discuss how the company is evolving.

They’ll discuss how DePuy Synthes is changing its product development process, setting up a s…

How Insulet created its next-gen Omnipod 5

Insulet (NSDQ:PODD) added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January.

Omnipod 5 provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks. Paired with Dexcom’s G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery system. Users can use a dedicated handheld controller or control the system with a secure app on their smartphone, marking another first.

Join us at DeviceTalks Boston on May 10-11, 2022, for a keynote interview with Insulet CEO Shacey Petrovic to learn about the story behind the game-changing Omnipod 5.

DeviceTalks Boston will unite medtech’s most innovative professionals and help attendees clear troublesome bottlenecks in the critical stages of medical device development. We will explore the trends and technology that are shaping the future of the medical device…